Phenoxybenzamine Versus Doxazosin in PCC Patients (PRESCRIPT)
Pheochromocytoma Randomised Study Comparing Adrenoreceptor Inhibiting Agents for Preoperative Treatment
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
This PHASE4 trial investigates Pheochromocytoma and is currently completed. Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) leads this study, which shows 9 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Oct 2024 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Oct 2024 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Mar 2022 — Jul 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Mar 2022 [monthly]
Completed PHASE4
▶ Show 4 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Feb 2018 — Jun 2018 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Feb 2017 — Feb 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Dec 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Atrium Medical Center
- Canisius-Wilhelmina Hospital
- Erasmus Medical Center
- Isala
- Leiden University Medical Center
- Maastricht University Medical Center
- Maxima Medical Center
- Medisch Spectrum Twente
- Onze Lieve Vrouwe Gasthuis
- Radboud University Medical Center
- St. Antonius Hospital
- UMC Utrecht
- University Medical Center Groningen
- VU University of Amsterdam
For direct contact, visit the study record on ClinicalTrials.gov .